Aprea Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Deduction, Percent
Aprea Therapeutics, Inc. (APRE) reported Effective Income Tax Rate Reconciliation, Deduction, Percent of 0.10% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationDeductions · last filed 2026-03-16
- Aprea Therapeutics, Inc. effective income tax rate reconciliation, deduction, percent for fiscal 2024 was 0.10%.
- Aprea Therapeutics, Inc. effective income tax rate reconciliation, deduction, percent for fiscal 2022 was 0.60%.
- Aprea Therapeutics, Inc. effective income tax rate reconciliation, deduction, percent for fiscal 2020 was 1.70%, a 54.05% decline from fiscal 2019.
- Aprea Therapeutics, Inc. effective income tax rate reconciliation, deduction, percent for fiscal 2019 was 3.70%, a 825.00% increase from fiscal 2018.
| Period end | Effective Income Tax Rate Reconciliation, Deduction, Percent 12 month | Effective Income Tax Rate Reconciliation, Deduction, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | 0.10% 10-K · filed 2026-03-16 | |
| 2022-12-31 | 0.60% 10-K · filed 2024-03-26 | -0.60% 10-K · filed 2023-03-30 |
| 2020-12-31 | 1.70% 10-K · filed 2023-03-30 | |
| 2019-12-31 | 3.70% 10-K · filed 2022-03-15 | |
| 2018-12-31 | 0.40% 10-K · filed 2021-03-16 | |
| 2017-12-31 | -0.10% 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |